EVOKE PHARMA INC (EVOK) Forecast, Price Target & Analyst Ratings

NASDAQ:EVOK • US30049G3020

Current stock price

11 USD
+0.04 (+0.36%)
Last:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EVOKE PHARMA INC (EVOK).

Forecast Snapshot

Consensus Price Target

Price Target
$18.36
+ 66.91% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Mar 11, 2026
Period
Q4 / 2025
EPS Estimate
-$0.31
Revenue Estimate
4.954M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
43.33%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$18.36
Upside
+ 66.91%
From current price of $11.00 to mean target of $18.36, Based on 6 analyst forecasts
Low
$18.18
Median
$18.36
High
$18.90

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

6 Wall Street analysts provided a forecast for the next 12 months for EVOK. The average price target is 18.36 USD. This implies a price increase of 66.91% is expected in the next year compared to the current price of 11.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

EVOK Current Analyst RatingEVOK Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

EVOK Historical Analyst RatingsEVOK Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
43.33%
EVOK was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about EVOK.
In the last month the buy percentage fell by 40 points. So the trust of analysts is decreasing.
EVOK was analyzed by 6 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Next Earnings Forecast Details

Next Earnings Details

Release Date
Mar 11, 2026
Period
Q4 / 2025
EPS Estimate
-$0.31
Revenue Estimate
4.954M
Revenue Q2Q
49.71%
EPS Q2Q
51.43%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
4.29%
EPS (1 Month)
0.00%
EPS (3 Months)
23.08%

Next Earnings Summary

EVOK is expected to report earnings on 3/11/2026. The consensus EPS estimate for the next earnings is -0.31 USD and the consensus revenue estimate is 4.95M USD.
The next earnings revenue estimate has been revised upward by 4.29% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2027

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
EVOK revenue by date.EVOK revenue by date.
2.51M
54.94%		5.181M
106.40%		10.249M
97.84%		16.292M
58.96%		25.74M
57.99%		36.321M
41.11%
EBITDA
YoY % growth
EVOK ebitda by date.EVOK ebitda by date.
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
EVOK ebit by date.EVOK ebit by date.
-7.79M
4.42%		-7.431M
4.61%		-5.204M
29.97%		-4.922M
5.43%		2.156M
143.81%		10.126M
369.67%
Operating Margin
EVOK operating margin by date.EVOK operating margin by date.
-310.36%-143.44%-50.77%-30.21%8.38%27.88%
EPS
YoY % growth
EVOK eps by date.EVOK eps by date.
-32.16
17.28%		-27.96
13.06%		-4.54
83.76%		-1.92
57.76%		0.69
136.17%		2.09
201.47%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q4 / 25
EPS
Q2Q % growth		-0.31
51.43%
Revenue
Q2Q % growth		4.954M
49.71%
EBITDA
Q2Q % growth		N/A
EBIT
Q2Q % growth		-843.54K
29.33%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

EVOK Yearly Revenue VS EstimatesEVOK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M
EVOK Yearly EPS VS EstimatesEVOK Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -50 -100 -150 -200 -250

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
35.00%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
52.59%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

EVOKE PHARMA INC / EVOK Forecast FAQ

What do analysts expect the price target to be for EVOKE PHARMA INC (EVOK)?

6 analysts have analysed EVOK and the average price target is 18.36 USD. This implies a price increase of 66.91% is expected in the next year compared to the current price of 11.

Can you provide the upcoming earnings date for EVOKE PHARMA INC?

EVOKE PHARMA INC (EVOK) will report earnings on 2026-03-11, after the market close.

Can you provide the consensus estimates for EVOKE PHARMA INC next earnings?

The consensus EPS estimate for the next earnings of EVOKE PHARMA INC (EVOK) is -0.31 USD and the consensus revenue estimate is 4.95M USD.

How do analysts rate EVOKE PHARMA INC (EVOK)?

The consensus rating for EVOKE PHARMA INC (EVOK) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.